Cargando…
Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672584/ https://www.ncbi.nlm.nih.gov/pubmed/23153017 http://dx.doi.org/10.1186/cc11836 |
| _version_ | 1782272130987065344 |
|---|---|
| author | Hunsicker, Oliver Francis, Roland C |
| author_facet | Hunsicker, Oliver Francis, Roland C |
| author_sort | Hunsicker, Oliver |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3672584 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36725842013-11-15 Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? Hunsicker, Oliver Francis, Roland C Crit Care Letter BioMed Central 2012 2012-11-15 /pmc/articles/PMC3672584/ /pubmed/23153017 http://dx.doi.org/10.1186/cc11836 Text en Copyright ©2012 BioMed Central Ltd |
| spellingShingle | Letter Hunsicker, Oliver Francis, Roland C Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title | Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title_full | Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title_fullStr | Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title_full_unstemmed | Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title_short | Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| title_sort | assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis: how to guide fluid therapy? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672584/ https://www.ncbi.nlm.nih.gov/pubmed/23153017 http://dx.doi.org/10.1186/cc11836 |
| work_keys_str_mv | AT hunsickeroliver assessmentofhemodynamicefficacyandsafetyof6hydroxyethylstarch13004vs09naclfluidreplacementinpatientswithseveresepsishowtoguidefluidtherapy AT francisrolandc assessmentofhemodynamicefficacyandsafetyof6hydroxyethylstarch13004vs09naclfluidreplacementinpatientswithseveresepsishowtoguidefluidtherapy |